Prospective cohort studies of association between family history of liver cancer and risk of liver cancer

International Journal of Cancer

Volumn 135, Issue 7, 2014, Pages 1605-1614

  Yang, Yang ^a,b   Wu, Qi Jun ^a,b   Xie, Li ^a,b   Chow, Wong Ho ^c   Rothman, Nat ^d   Li, Hong Lan ^b   Gao, Yu Tang ^b   Zheng, Wei ^e   Shu, Xiao Ou ^e   Xiang, Yong Bing ^a,b  

^a School of Medicine   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cohort studies; family history of liver cancer; liver cancer; meta analysis

Indexed keywords

ADULT; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER RISK; CHINESE; CHOLELITHIASIS; COHORT ANALYSIS; CONTROLLED STUDY; EDUCATION; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; HAZARD RATIO; HEPATITIS; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SYSTEMATIC REVIEW;

COHORT STUDIES; FAMILY HISTORY OF LIVER CANCER; LIVER CANCER; META-ANALYSIS;

ADULT; AGED; CASE-CONTROL STUDIES; CHINA; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84904499056     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28792     Document Type: Article

References (61)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Gao S, Yang WS, Bray F, et al. Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005. Eur J Epidemiol 2012; 27: 39-46.
3. El-Serag HB,. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142: 1264-73.e1.
4. Chen CH, Huang GT, Lee HS, et al. Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma. J Clin Gastroenterol 1998; 27: 236-9.
5. Yu MW, Chang HC, Liaw YF, et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 2000; 92: 1159-64.
6. Hemminki K, Li X,. Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden. Gut 2003; 52: 592-6.
7. Shen FM, Lee MK, Gong HM, et al. Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infection. Am J Hum Genet 1991; 49: 88-93.
8. Shih WL, Yu MW, Chen PJ, et al. Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area. Oncogene 2006; 25: 3219-24.
9. Shih WL, Yu MW, Chen PJ, et al. Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study. Eur J Hum Genet 2009; 17: 1250-9.
10. Hassan MM, Spitz MR, Thomas MB, et al. The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. J Hepatol 2009; 50: 334-41.
11. Turati F, Edefonti V, Talamini R, et al. Family history of liver cancer and hepatocellular carcinoma. Hepatology 2012; 55: 1416-25.
12. Sun Z, Lu P, Gail MH, et al. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology 1999; 30: 379-83.
13. Zhu GT, Lou GQ, Shi JP,. [To investigate the relationship of alcohol intake and hepatocellular carcinoma among patients with hepatitis B virus infection]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2011; 25: 328-30.
14. Tarleton HP, Chang SC, Park SL, et al. Genetic variation at 8q24, family history of cancer, and upper gastrointestinal cancers in a Chinese population. Fam Cancer 2014; 13: 45-56.
15. Evans AA, Chen G, Ross EA, et al. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 2002; 11: 369-76.
16. Chen QY, Dong BQ, Yang JY, et al. [A prospective study of the relationship between serum hepatitis B virus DNA and the risk of primary liver cancer]. Zhonghua Gan Zang Bing Za Zhi 2009; 17: 930-4.
17. Loomba R, Liu J, Yang HI, et al. Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma. Clin Gastroenterol Hepatol 2013; 11: 1636-45.e1-3.
18. van Esch A, Steyerberg EW, Berger MY, et al. Family history and recurrence of febrile seizures. Arch Dis Child 1994; 70: 395-9.
19. Zheng W, Chow WH, Yang G, et al. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 2005; 162: 1123-31.
20. Cai H, Zheng W, Xiang YB, et al. Dietary patterns and their correlates among middle-aged and elderly Chinese men: a report from the Shanghai Men's Health Study. Br J Nutr 2007; 98: 1006-13.
21. Lin J,. [A study on aetiological factors of primary hepato-carcinoma in Tianjin China]. Zhonghua Liu Xing Bing Xue Za Zhi 1991; 12: 346-9.
22. Zhang MD,. [A population-based case control study of primary liver cancer in Fusui]. Zhonghua Liu Xing Bing Xue Za Zhi 1993; 14: 14-8.
23. Fernandez E, La Vecchia C, D'Avanzo B, et al. Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 1994; 3: 209-12.
24. Zhao N, Yu SZ, Sun WM,. [Modelling the general relative risk models in case-control studies of primary hepatocellular carcinoma]. Zhonghua Zhong Liu Za Zhi 1994; 16: 331-6.
25. Donato F, Gelatti U, Chiesa R, et al. A case-control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in North Italy. Brescia HCC Study. Cancer Causes Control 1999; 10: 417-21.
26. Lu P, Wang J, Wu Y,. [Significance of prospective follow-up cohort study in diagnosis and treatment of primary hepatic cancer among HBsAg carriers]. Zhonghua Yi Xue Za Zhi 2001; 81: 856-9.
27. Zhu ZZ, Cong WM, Liu SF, et al. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection. Cancer Lett 2005; 229: 77-83.
28. Hsu LM, Huang YS, Yang SY, et al. Polymorphism of T-cell receptor gamma short tandem repeats as a susceptibility risk factor of hepatocellular carcinoma. Anticancer Res 2006; 26: 3787-91.
29. Tan SK, Qiu XQ, Yu HP, et al. [Etiologic fraction and interaction of risk factors for primary hepatic carcinoma in Guangxi, China]. Zhonghua Yu Fang Yi Xue Za Zhi 2008; 42: 169-72.
30. Wan DW, Tzimas D, Smith JA, et al. Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States. Am J Gastroenterol 2011; 106: 1994-2000.
31. He J, Zhang Q, Ren Z, et al. Cyclooxygenase-2-765 G/C polymorphisms and susceptibility to hepatitis B-related liver cancer in Han Chinese population. Mol Biol Rep 2012; 39: 4163-8.
32. Li Q, Li WW, Yang X, et al. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B. Int J Cancer 2012; 131: 1197-202.
33. Yuan T, Wei J, Luo J, et al. Polymorphisms of base-excision repair genes hOGG1 326cys and XRCC1 280His increase hepatocellular carcinoma risk. Dig Dis Sci 2012; 57: 2451-7.
34. Chen TH, Chen CJ, Yen MF, et al. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer 2002; 98: 257-61.
35. Lee MH, Yang HI, Liu J, et al. Prediction models of long-term cirrhosis and HCC risk in chronic hepatitis B patients: risk scores integrating host and virus profiles. Hepatology 2013; 58: 546-54.
36. Zhang MD,. [Aflatoxins and primary liver cancer-a population based case-control study]. Zhonghua Yu Fang Yi Xue Za Zhi 1992; 26: 331-3.
37. Turati F, Edefonti V, Bosetti C, et al. Family history of cancer and the risk of cancer: a network of case-control studies. Ann Oncol 2013; 24: 2651-6.
38. Hassan MM, Kaseb A, Li D, et al. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology 2009; 49: 1563-70.
39. Huang YS, Chern HD, Wu JC, et al. Polymorphism of the N-acetyltransferase 2 gene, red meat intake, and the susceptibility of hepatocellular carcinoma. Am J Gastroenterol 2003; 98: 1417-22.
40. London WT, Evans AA, McGlynn K, et al. Viral, host and environmental risk factors for hepatocellular carcinoma: a prospective study in Haimen City, China. Intervirology 1995; 38: 155-61.
41. Yu MW, Yang SY, Chiu YH, et al. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 1999; 29: 697-702.
42. Liu TT, Fang Y, Xiong H, et al. A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China. World J Gastroenterol 2008; 14: 3059-63.
43. Zou CL, Chen ZJ, Jin WY, et al. [Etiologic fraction and interaction of risk factors for primary hepatocellular carcinoma in Wenzhou, Zhejiang Province]. Zhonghua Yu Fang Yi Xue Za Zhi 2003; 37: 355-7.
44. Tanaka K, Hirohata T, Takeshita S, et al. Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Int J Cancer 1992; 51: 509-14.
45. Tsukuma H, Hiyama T, Oshima A, et al. A case-control study of hepatocellular carcinoma in Osaka, Japan. Int J Cancer 1990; 45: 231-6.
46. Chen CJ, Liang KY, Chang AS, et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991; 13: 398-406.
47. Stang A,. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-5.
48. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
49. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
50. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
51. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
52. Zhang H, Zhai Y, Hu Z, Wu C, Qian J, Jia W, Ma F, Huang W, Yu L, Yue W, Wang Z, Li P, et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 2010; 42: 755-8.
53. Jiang DK, Sun J, Cao G, Liu Y, Lin D, Gao YZ, Ren WH, Long XD, Zhang H, Ma XP, Wang Z, Jiang W, et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet 2013; 45: 72-5.
54. Xie J, Zhang Y, Zhang Q, Han Y, Yin J, Pu R, Shen Q, Lu W, Du Y, Zhao J, Han X, Zhang H, et al. Interaction of signal transducer and activator of transcription 3 polymorphisms with HBV mutations in hepatocellular carcinoma. Hepatology 2013.
55. Volk ML, Lok ASF,. Is family history of liver cancer a risk factor for hepatocellular carcinoma? Journal of Hepatology 2009; 50: 247-8.
56. de Martel C, Forman D, Plummer M,. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am 2013; 42: 219-40.
57. Yadav D, Lowenfels AB,. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013; 144: 1252-61.
58. Hassan MM, Li D, El-Deeb AS, Wolff RA, Bondy ML, Davila M, Abbruzzese JL,. Association between hepatitis B virus and pancreatic cancer. J Clin Oncol 2008; 26: 4557-62.
59. Murad H, Kalter-Leibovici O, Chetrit A, Freedman LS,. A statistical comparison of different family history scores. Stat Med 2007; 26: 2785-98.
60. Murff HJ, Spigel DR, Syngal S,. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 2004; 292: 1480-9.
61. Mitchell RJ, Brewster D, Campbell H, Porteous ME, Wyllie AH, Bird CC, Dunlop MG,. Accuracy of reporting of family history of colorectal cancer. Gut 2004; 53: 291-5.